超极化代谢成像检测局部治疗后残留的潜伏性肝细胞癌区域
该研究利用动态核极化磁共振波谱成像(DNP-MRSI)检测经动脉栓塞(TAE)后存活的潜伏性肝细胞癌(HCC)细胞。TAE诱导缺血使潜伏HCC细胞代谢降低并依赖糖酵解生成乳酸,DNP-MRSI检测1-13C-丙酮酸及其下游代谢物可预测组织学活力。研究为成像治疗抵抗的潜伏癌细胞提供了新 paradigm。
要点
- TAE后潜伏HCC细胞代谢降低,依赖糖酵解通量生成乳酸。
- DNP-MRSI检测1-13C-丙酮酸、乳酸和丙氨酸可预测组织学活力。
- 该技术有望用于成像治疗抵抗的潜伏癌细胞。
核心结论
- DNP-MRSI可检测TAE后存活的潜伏性HCC细胞,预测组织学活力。
研究设计与样本
- 本研究为临床前研究,利用TAE诱导缺血的HCC模型,采用DNP-MRSI对13碳标记底物进行成像。
主要发现
- TAE诱导缺血下,潜伏HCC细胞代谢降低并依赖糖酵解通量生成乳酸。
- 尽管细胞处于低代谢状态,DNP-MRSI检测1-13C-丙酮酸及其下游代谢物1-13C-乳酸和1-13C-丙氨酸仍能预测组织学活力。
临床怎么用
- DNP-MRSI可能成为检测局部治疗后潜伏癌细胞的成像技术,辅助识别复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Advances in cancer treatment have improved survival; however, local recurrence and metastatic disease-the principal causes of cancer mortality-have limited the ability to achieve durable remissions. Local recurrences arise from latent tumor cells that survive therapy and are often not detectable by conventional clinical imaging techniques. Local recurrence after transarterial embolization (TAE) of hepatocellular carcinoma (HCC) provides a compelling clinical correlate of this phenomenon. In response to TAE-induced ischemia, HCC cells adapt their growth program to effect a latent phenotype that precedes local recurrence. APPROACH AND RESULTS: In this study, we characterized and leveraged the metabolic reprogramming demonstrated by latent HCC cells in response to TAE-induced ischemia to enable their detection in vivo using dynamic nuclear polarization (DNP) magnetic resonance spectroscopic imaging (MRSI) of 13 carbon-labeled substrates. Under TAE-induced ischemia, latent HCC cells demonstrated reduced metabolism and developed a dependence on glycolytic flux to lactate. Despite the hypometabolic state of these cells, DNP-MRSI of 1-13 C-pyruvate and its downstream metabolites, 1-13 C-lactate and 1-13 C-alanine, predicted histological viability. CONCLUSIONS: These studies provide a paradigm for imaging latent, treatment-refractory cancer cells, suggesting that DNP-MRSI provides a technology for this application.
引用
- Perkons NR, Kiefer RM, Noji MC, et al. Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy. Hepatology. 2020. PMID: 31553806. doi:10.1002/hep.30970
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。